Expert Interview
Checking in with a prescriber of Axsome's SUNOSI (Solriamfetol) in treating excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea (OSA)
Ticker(s): AXSMInstitution: Stanford
- Clinical Associate Professor, Neurology & Neurological Sciences & Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine at Stanford.
- Manages 40 patients with narcolepsy and has prescribed SUNOSI.
- Research interests involve biomarkers of disease progression in REM sleep behavior disorder, and mechanisms and treatment of Postural Tachycardia Syndrome and Post-Acute COVID Syndrome; special interest in Autonomic Disorders, Sleep Disorders, and the interaction between these conditions.
On a scale of 1 to 10 how would you rate SUNOSI as an option for treating narcolepsy?
Added By: max_adminHow accessible is SUNOSI compared to similar medications on the market?
Added By: max_adminUnder what circumstances would you prescribe SUNOSI over another medication?
Added By: max_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
